Rollins is trading at $36.00, down 7.12% in pre-market, with no clear company-specific catalyst identified.
- No clear company-specific announcement dated November 6 was identified in the search.
- Rollins’ latest reported results, released October 21, included weaker-than-expected organic growth and reduced full-year organic-growth guidance. These are not a new overnight catalyst, and available evidence does not establish that they caused the decline.